The articles claim pharmaceutical companies are inventing diseases to increase sales figures while offering nothing about disease prevention.
Exerpt from one of the articles:
Disease mongering turns healthy people into patients, wastes precious resources, and causes iatrogenic harm. Like the marketing strategies that drive it, disease mongering poses a global challenge to those interested in public health, demanding in turn a global response. This theme issue of PLoS Medicine is explicitly designed to help provoke and inform that response.
No comments:
Post a Comment